Proton beam therapy for hepatocellular carcinoma unsuitable for surgery or local ablative therapies

Phase 2

• Conditions: Hepatocellular carcinoma

• Registration Number: JPRN-UMIN000020596
• Lead Sponsor: Department of Radiation Oncology, Hokkaido University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-01-18
• Study Completion: 2020-04-22
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

1)With other malignancies (simultaneous double cancer and heterochronic double cancer with disease-free time within 5 years), excluding lesions equivalent to carcinoma-in-situ or submucosal carcinoma 2)With esophageal or gastric varices at high risk for rupture within 28 days before registration 3)With active infection requiring systemic therapy 4)With a fever of 38 degrees Celsius or more 5)With cardiac infarction or unstable angina within 6 months before registration 6)With interstitial pneumonia, pulmonary fibrosis or severe pulmonary emphysema 7)Allergic to radiation 8)Considered that participation in this trial is difficult due to psychiatric symptoms or psychosis 9)Females who are pregnant, breast-feeding, within 28 days postpartum or have a possibility of conception 10)Considered that participation in this trial is difficult because of psychiatric symptoms or psychosis

Study & Design

• Study Type: Interventional
• Study Design: Not specified